Atea Pharmaceuticals, Inc. Share Price
NASDAQ: AVIR | Small CapAtea Pharmaceuticals, Inc. Stock Performance
Atea Pharmaceuticals, Inc. Share Price Today
As of 31 October 2026, Atea Pharmaceuticals, Inc.'s share price is $4.12. The stock opened at $4.24, compared to its previous close of $4.31. During today's trading session, Atea Pharmaceuticals, Inc.'s share price traded between $4.09 and $4.24, with an average price of $4.16. Over the past 52 weeks, the stock has recorded a high of $6.43 and a low of $2.92. In terms of performance, Atea Pharmaceuticals, Inc.'s share price has declined by 25.29% over the last six months and is up 27.16% on a year-on-year basis.
Atea Pharmaceuticals, Inc. Share Price Chart
Atea Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
Atea Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
Atea Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $5.11 | $4.09 | -21.42% |
Sep 2026 | $5.38 | $5.21 | -4.40% |
Aug 2026 | $4.70 | $5.45 | +16.08% |
Jul 2026 | $4.69 | $4.70 | +0.97% |
Jun 2026 | $4.55 | $4.65 | -0.11% |
May 2026 | $5.41 | $4.66 | -15.59% |
Apr 2026 | $5.43 | $5.51 | +2.60% |
Mar 2026 | $4.71 | $5.38 | +14.61% |
Feb 2026 | $4.18 | $4.69 | +10.61% |
Jan 2026 | $3.52 | $4.24 | +18.27% |
Dec 2025 | $3.05 | $3.58 | +16.02% |
Nov 2025 | $3.21 | $3.09 | -4.63% |